When I wrote on MAKO Surgical (MAKO)
in the wake of disappointing first quarter results, I mentioned an old
wives tale that says med-tech companies miss in threes. Based on
management's warning that second quarter results would come up short of
lowered expectation, it looks we may have one more yet to go.
Read more here:
MAKO's Blood Is In The Water
No comments:
Post a Comment